Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
29 Sep 2013 ESMO @ ECC 2013: Similar Phase III Results Reported for Dovitinib vs. Sorafenib Treatment in Patients with Metastatic Renal Cell Carcinoma Genitourinary cancers - Anticancer agents & Biologic therapy
29 Sep 2013 ESMO @ ECC 2013: Younger Age in Patients with Metastatic Colorectal Cancer Associates with Poorer Outcome Cancer in Special Situations - Gastrointestinal cancers
29 Sep 2013 ECC 2013 Press Release: Promising Results for New Antibody Drug in Non-Small Cell Lung Cancer Patients: Smokers Respond Well Lung and other thoracic tumours - Immuno-oncology
29 Sep 2013 ECC 2013 Press Release: Survival After Cancer Diagnosis in Europe is Strongly Associated with How Much Governments Spend on Health Care Bioethics, legal and economic issues
29 Sep 2013 ECC 2013 Press Release: Colorectal Cancer Screening Works; ‘Irrefutable’ Evidence that Fall in Death Rates is Attributable to Screening Programmes Cancer prevention - Gastrointestinal cancers
29 Sep 2013 ECC 2013 Press Release: Diabetes Increases the Risk of Developing and Dying from Breast and Colon Cancer Cancer prevention
29 Sep 2013 ECC 2013 Press Release: Young Patients with Metastatic Colorectal Cancer are at High Risk of Disease Progression and Death Cancer in Special Situations - Gastrointestinal cancers
29 Sep 2013 ECC 2013 Press Release: Everolimus Slows Disease Progression in Advanced Papillary Kidney Cancer Patients Genitourinary cancers - Anticancer agents & Biologic therapy
29 Sep 2013 ECC 2013 Press Release: Identifying the Disease-Causing Mechanisms in Cancers with an Unknown Primary Site Improves Treatment and Survival Pathology/Molecular biology - Carcinoma of unknown primary site
28 Sep 2013 ESMO @ ECC 2013: Vemurafenib in Patients With RAI Refractory, Progressive, BRAFV600E-mutated Papillary Thyroid Cancer Endocrine cancers - Anticancer agents & Biologic therapy
28 Sep 2013 ESMO @ ECC 2013: Belagenpumatucel-L Therapeutic Tumour Cell Vaccine for Non-Small Cell Lung Cancer Lung and other thoracic tumours - Immuno-oncology
28 Sep 2013 ESMO @ ECC 2013: Phase III FIRE-3 Trial Data Show Most Patients with Wild-Type RAS Metastatic Colorectal Cancer Benefit from First-Line FOLFIRI Plus Cetuximab Treatment Personalised medicine - Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Sep 2013 ECC 2013 Press Release: Treating Chest Lymph Nodes in Patients with Early Breast Cancer Improves Survival Without Increasing Side Effects Breast cancer
28 Sep 2013 ECC 2013 Press Release: Hyperfractionated Radiotherapy Improves Survival in Head and Neck Cancer Patients Head and neck cancers
28 Sep 2013 ESMO @ ECC 2013: Premenopausal High-Risk Breast Cancer Patients with Luminal A Tumours Benefit from Postmastectomy Radiation Breast cancer